|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cranial Ultrasonography in Neonates: Role and Limitations显示文摘 | Gerda van Wezel-Meijler Sylke J. Steggerda Lara M. Leijser | 2010 | Seminars in Perinatology2010，，1： | 2 |
| 2 | On the use of Ringer-Locke solution containing hemoglobin as a substitute for normal blood in mammals显示文摘 | Amberson WR Flexn J Steggerda FR | 1971 | J Cell Comp Physiol1971，77，3： | 1 |
| 3 | Cranial ultra- sonography in neonates: role and limitations 显示文摘 | van Wezel - Meijler G Steggerda SJ Leijser LM | 2010 | Semin Perinatol2010，34，1： | 1 |
| 4 | Cranial ultra-sonography in neonates: role and limitations 显示文摘 | van Wezel-Meijler G Steggerda SJ Leijer LM | 2010 | Semin Peri-natol2010，34，1： | 1 |
| 5 | Periprocedural complications and long-term outcome after alcohol septal ablation surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience 显示文摘 | Steggerda RC Damman K Bait JC | 2014 | JACC Cardiovasc Interv2014，7，11： | 1 |
| 6 | Gastrointestinal gas following food consumption 显示文摘 | Steggerda F R | 1968 | Ann N Y Acad Sci1968，150，： | 1 |
| 7 | The patient with hypearophic cardiomyopathy 显示文摘 | Berg J Steggerda RC Siebelink HM | 2010 | Heart2010，96，21： | 1 |
| 8 | Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology 显示文摘 | Bell KFS Kort GJLD Steggerda S | 2004 | Neurosci Lett2004，353，2： | 1 |
| 9 | Cranial ultrasonography in neonates:role and limitations显示文摘 | van Wezel-Meijler G Steggerda SJ Leijser LM | | 0，，1： | 1 |
| 10 | Synthesis and spectroscopic characterization of 13C-labeled ubiquinone-0 and ubiquinone-10 显示文摘 | van Liemt WBS Steggerda WF Esmeijer R | 1994 | Recl Trav Chim Pays-Bas1994，113，3： | 1 |
| 11 | Cranial ul- trasonography in neonates: role and limitations 显示文摘 | van Wezel-Meiiler G Steggerda S J Leijser L M | 2010 | Semin Perinatol2010，34，1： | 1 |
| 12 | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge显示文摘Non-alcoholic steatohepatitis(NASH)is the most common chronic liver disease worldwide,and the fastest growing indication for liver transplantation in the United States.NASH is now the leading etiology for liver transplantation in women,the second leading indication for men,and the most common cause amongst recipients aged 65 years and older.Patients with end-stage liver disease related to NASH represent a unique and challenging patient population due the high incidence of associated comorbid diseases,including obesity,type 2 diabetes(T2D),and hypertension.These challenges manifest in the pre-liver transplantation period with increased waitlist times and waitlist mortality.Furthermore,these patients carry considerable risk of morbidity and mortality both before after liver transplantation,with high rates of T2D,cardiovascular disease,chronic kidney disease,poor nutrition,and disease recurrence.Successful transplantation for these patients requires identification and management of their comorbidities in the face of liver failure.Multidisciplinary evaluations include a thorough pre-transplant workup with a complete cardiac evaluation,control of diabetes,nutritional support,and even,potentially,consultation with a bariatric surgeon.This article provides a comprehensive review of the conditions and challenges facing patients with NASH cirrhosis undergoing liver transplantation and provides recommendations for evaluation and management to optimize them before liver transplantation to produce successful outcomes. | Justin A Steggerda Krishnaraj Mahendraraj Tsuyoshi Todo Mazen Noureddin | 2020 | World Journal of Gastroenterology2020，26，28： | 1 |
| 13 | Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology 显示文摘 | Bell K de Kort G Steggerda S | 2003 | Neurosci Lett2003，353，2： | 1 |
| 14 | Cerebellar In-jury in Preterm Infants:Incidence and Findings on US and MR Ima-gesl 显示文摘 | Steggerda SJ Leijser LM Wiggers-de Bru? ne FT | 2009 | Radiology2009，252，1： | 1 |
| 15 | Synthesis and Spectroscopic Characterization of 13C-Labelled Ubiquinone-0 and Ubiquinone10显示文摘 | Liemt V Steggerda W | 1994 | Recl Trav Chim Pays-Bas1994，113，3： | 1 |
| 16 | Structural involvement of the glu- tamatergic presynaptic boutons in a transgenie mouse model expressing early onset amyloid pathology显示文摘 | Bell KF de Kort GJ Steggerda S | 2003 | Neurosci Lett2003，353，2： | 1 |
| 17 | Flavor and flatu-lence factors in soybean protein products 显示文摘 | Rackis J J Honig D H Sessa D J Steggerda F R | 1970 | Journal of Agriculturaland Food Chemistry1970，，18： | 1 |
| 18 | Lenticulostriate vasculopathy in very preterm infants显示文摘 | Leijser LM Steggerda SJ de Bru?ne FT | | 0，，01： | 1 |
| 19 | Ibrutinib Resistance in Chronic Lymphocytic Leukemia显示文摘 | Richard R. Furman Shuhua Cheng Pin Lu Menu Setty Alexendar R. Perez Ailin Guo Joelle Racchumi Guozhou Xu Hao Wu Jiao Ma Susanne M. Steggerda Morton Coleman Christina Leslie Y. Lynn Wang | 2014 | The New England Journal of Medicine2014，，24： | 1 |
| 20 | On the use of RingerLocke solution containing hemoblobin as a substitute for normal blood in mammals显示文摘 | Amberson WR Flexner J Steggerda FR | 1934 | J Cell Comp Physiol1934，5，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员